Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb pet

Journal of Nuclear Medicine

Volumn 55, Issue 12, 2014, Pages 1952-1958

  Murthy, Venkatesh L ^a,b   Lee, Benjamin C ^c   Sitek, Arkadiusz ^d   Naya, Masanao ^a   Moody, Jonathan ^c   Polavarapu, Vivek ^b   Ficaro, Edward P ^b,c   Di Carli, Marcelo F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c INVIA Medical Imaging Solutions   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

82Rb; Myocardial flow reserve; Myocardial perfusion imaging

Indexed keywords

RUBIDIUM 82; RUBIDIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; FACTORIAL ANALYSIS; FEMALE; FRACTIONAL FLOW RESERVE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; VALIDATION PROCESS; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY DISEASE; DIAGNOSTIC USE; EXERCISE TEST; HEART; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY CIRCULATION; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RUBIDIUM RADIOISOTOPES;

EID: 84915815348     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.145342     Document Type: Article

References (34)

1. 13Nammonia myocardial perfusion positron emission tomography: added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150-156.
2. Tio RA, Dabeshlim A, Siebelink H-MJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med. 2009;50:214-219.
3. Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124: 2215-2224.
4. Ziadi MC, Dekemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-748.
5. 82Rb PET perfusion imaging. J Nucl Med. 2011;52:726-732.
6. Farhad H, Dunet V, Bachelard K, Allenbach G, Kaufmann PA, Prior JO. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J Cardiovasc Imaging. 2013;14:1203-1210.
7. Ziadi MC, Dekemp RA, Williams K, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19:670-680.
8. 13N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53:1230-1234.
9. Naya M, Murthy VL, Taqueti VR, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014;55:248-255.
10. Joutsiniemi E, Saraste A, Pietilä M, et al. Absolute flow or myocardial flow reserve for the detection of significant coronary artery disease? Eur Heart J Cardiovasc Imaging. 2014;15:659-665.
11. Mullani NA, Goldstein RA, Gould KL, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med. 1983;24:898-906.
12. Glatting G, Bergmann KP, Stollfuß JC, et al. 1011-116 Myocardial Rb extraction fraction: determination in humans. J Am Coll Cardiol. 1995;25:364A-365A.
13. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701-1712.
14. Schelbert HR. Positron emission tomography of the heart: methodology, findings in the normal and the diseased heart, and clinical applications. In: PET: Molecular Imaging and Its Biological Applications. New York, NY: Springer; 2004:389-508.
15. 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-1774.
16. 15O-water. Eur J Nucl Med Mol Imaging. 2012;39:1037-1047.
17. 82Rb PET using generalized factor and compartment analyses. J Nucl Med. 2005;46:1264-1271.
18. 13N-ammonia PET. J Nucl Med. 2009;50:1062-1071.
19. 82Rb kinetics. J Nucl Med. 2013;54:571-577.
20. 82Rb PET imaging: Results of RUBY-10 Study. JACC Cardiovasc Imaging. October 1, 2014 [Epub ahead of print].
21. 82Rb PET/CT: comparison of different software packages and methods. Eur J Nucl Med Mol Imaging. 2014;41:126-135.
22. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105:539-542.
23. Crone C. The permeability of capillaries in various organs as determined by use of the "indicator diffusion" method. Acta Physiol Scand. 1963;58:292-305.
24. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol. 1959;197:1205-1210.
25. Murthy VL, Naya M, Foster CR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858-1868.
26. Murthy VL, Naya M, Foster CR, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012;5:1025-1034.
27. Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-2527.
28. Kolthammer JA, Muzic RF. Optimized dynamic framing for PET-based myocardial blood flow estimation. Phys Med Biol. 2013;58:5783-5801.
29. Lee B, Moody J, Murthy V, Corbett J, Ficaro E. Effects of temporal sampling on PET myocardial blood flow estimates [abstract]. J Nucl Med. 2014;55 (suppl 1):1775.
30. Lee B, Moody J, Sitek A, et al. Effects of filtering on Rb-82 myocardial blood flow estimates [abstract]. J Nucl Med. 2013;54(suppl 2):1659.
31. Armstrong IS, Tonge CM, Arumugam P. Impact of point spread function modeling and time-of-flight on myocardial blood flow and myocardial flow reserve measurements for rubidium-82 cardiac PET. J Nucl Cardiol. 2014;21:467-474.
32. 13N-ammonia PET. J Nucl Med. 2007;48:1259-1265.
33. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW. Myocardial metabolism of fluorodeoxyglucose compared with cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med. 1991;32:1-9.
34. vom Dahl J, Muzik O, Wolfe ER, Allman C, Hutchins G, Schwaiger M. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as a marker of myocardial cell membrane integrity and viability. Circulation. 1996;93:238-245.